{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T20:30:42Z","timestamp":1780086642638,"version":"3.54.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2009,6,4]],"date-time":"2009-06-04T00:00:00Z","timestamp":1244073600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Infection"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1007\/s15010-009-8342-x","type":"journal-article","created":{"date-parts":[[2009,6,6]],"date-time":"2009-06-06T00:08:38Z","timestamp":1244246918000},"page":"461-465","source":"Crossref","is-referenced-by-count":83,"title":["Effectiveness and safety of colistin for the treatment of multidrug-resistant Pseudomonas aeruginosa infections"],"prefix":"10.1007","volume":"37","author":[{"given":"M.","family":"Montero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. P.","family":"Horcajada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Sorl\u00ed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Alvarez-Lerma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Grau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Riu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Sala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Knobel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,6,4]]},"reference":[{"key":"8342_CR1","doi-asserted-by":"crossref","first-page":"4425","DOI":"10.1021\/bi00587a024","volume":"18","author":"M. Shindler","year":"1979","unstructured":"Shindler M, Osborm MJ: Interaction of divalent cations and polymyxins B with lipopolysaccharide. Biochemistry 1979; 18: 4425\u20134430.","journal-title":"Biochemistry"},{"key":"8342_CR2","doi-asserted-by":"crossref","first-page":"923","DOI":"10.5694\/j.1326-5377.1970.tb63262.x","volume":"2","author":"J.M. Brown","year":"1970","unstructured":"Brown JM, Dorman DC, Roy LP: Acute renal failure due to over usage of colistin. Med J Aust 1970; 2: 923\u2013924.","journal-title":"Med J Aust"},{"key":"8342_CR3","doi-asserted-by":"crossref","first-page":"R27","DOI":"10.1186\/cc3995","volume":"10","author":"M.E. Falagas","year":"2006","unstructured":"Falagas ME, Kasiakou SK: Toxicity of polymyxins: a systematic review of the evidence from old and recent studies. Crit Care 2006; 10: R27.","journal-title":"Crit Care"},{"key":"8342_CR4","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1086\/429323","volume":"40","author":"M.E. Falagas","year":"2005","unstructured":"Falagas ME, Kasiakou SK: Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. Clin Infect Dis 2005; 40: 1333\u20131341.","journal-title":"Clin Infect Dis"},{"key":"8342_CR5","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1469-0691.2004.01043.x","volume":"11","author":"A.S. Michalopoulos","year":"2005","unstructured":"Michalopoulos AS, Tsiodras S, Rellos K, Mentzelopoulos S, Falagas ME: Colistin treatment in patients with ICU-acquired infections caused by multiresistant Gram-negative bacteria: the renaissance of an old antibiotic. Clin Microbiol Infect 2005; 11: 115\u2013121.","journal-title":"Clin Microbiol Infect"},{"key":"8342_CR6","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1007\/s00134-005-2691-4","volume":"31","author":"R. Reina","year":"2005","unstructured":"Reina R, Estenssoro E, Saenz G, Canales HS, Gonzalvo R, Vidal G, Martins G, Das Neves A, Santander O, Ramos C: Safety and efficacy of colistin in Acinetobacter and Pseudomonas infections: a prospective cohort study. Intensive Care Med 2005; 31: 1058\u20131065.","journal-title":"Intensive Care Med"},{"key":"8342_CR7","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ajic.2008.03.002","volume":"36","author":"T.C. Horan","year":"2008","unstructured":"Horan TC, Andrus M, Dudeck MA: CDC\/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008; 36: 309\u2013332.","journal-title":"Am J Infect Control"},{"key":"8342_CR8","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","volume":"30","author":"C.A. Naranjo","year":"1981","unstructured":"Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA: A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30: 239\u2013245.","journal-title":"Clin Pharmacol Ther"},{"key":"8342_CR9","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3121\/cmr.4.2.138","volume":"4","author":"M.E. Falagas","year":"2006","unstructured":"Falagas ME, Kasiakou SK, Tsiodras S, Michalopoulos AS: The use of intravenous and aerosolized polymyxins for the treatment of infections in critically III patients: a review of the recent literature. Clin Med Res 2006; 4: 138\u2013146.","journal-title":"Clin Med Res"},{"key":"8342_CR10","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.ijantimicag.2006.07.008","volume":"28","author":"H. Kallel","year":"2006","unstructured":"Kallel H, Bahloul M, Hergafi L, Akrout M, Ketata W, Chelly H, Hamida CB, Rekik N, Hammami A, Bouaziz M: Colistin as a salvage therapy for nosocomial infections caused by multidrug-resistant bacteria in the ICU. Int J Antimicrob Agents 2006; 28: 366\u2013369.","journal-title":"Int J Antimicrob Agents"},{"key":"8342_CR11","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.ijid.2006.09.011","volume":"11","author":"P. Koomanachai","year":"2007","unstructured":"Koomanachai P, Tiengrim S, Kiratisin P, Thamlikitkul V: Efficacy and safety of colistin (colistimethate sodium) for therapy of infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii in Siriraj Hospital, Bangkok, Thailand. Int J Infect Dis 2007; 11: 402\u2013406.","journal-title":"Int J Infect Dis"},{"key":"8342_CR12","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1471-2334-5-24","volume":"5","author":"M.E. Falagas","year":"2005","unstructured":"Falagas ME, Bliziotis IA, Kasiakou SK, Samonis G, Athanassopoulou P, Michalopoulous A: Outcome of infections due to pandrug-resistant (PDR) Gram-negative bacteria. BMC Infect Dis 2005; 5: 24.","journal-title":"BMC Infect Dis"},{"key":"8342_CR13","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1086\/514732","volume":"28","author":"A.S. Levin","year":"1999","unstructured":"Levin AS, Barone AA, Pen\u00e7o J, Santos MV, Marinho IS, Arruda EA, Manrique EI, Costa SF: Intravenous colistin as therapy of nosocomial infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii. Clin Infect Dis 1999; 28: 1008\u20131011.","journal-title":"Clin Infect Dis"},{"key":"8342_CR14","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1179\/joc.2003.15.3.235","volume":"15","author":"E.J. Giamarellos-Bourboulis","year":"2003","unstructured":"Giamarellos-Bourboulis EJ, Sambatakou H, Galani I, Giamarellou H: In vitro interaction of colistin and rifampin on multidrug-resistant Pseudomonas aeruginosa. J Chemother 2003; 15: 235\u2013238.","journal-title":"J Chemother"},{"key":"8342_CR15","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1093\/jac\/41.4.494","volume":"41","author":"G.M. Hogg","year":"1998","unstructured":"Hogg GM, Barr JG, Webb CH: In vitro activity of the combination of colistin and rifampicin against multidrug-resistant strains of Acinetobacter baumannii. J Antimicrob Chemother 1998; 41: 494\u2013495.","journal-title":"J Antimicrob Chemother"},{"key":"8342_CR16","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1469-0691.1999.tb00095.x","volume":"5","author":"A.P. MacGowan","year":"1999","unstructured":"MacGowan AP, Rynn C, Wootton M, Bowker KE, Holt HA, Reeves DS: In vitro assessment of colistin\u2019s antipseudomonal antimicrobial interactions with other antibiotics. Clin Microbiol Infect 1999; 5: 32\u201336.","journal-title":"Clin Microbiol Infect"},{"key":"8342_CR17","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1093\/jac\/dkg478","volume":"52","author":"S. Oie","year":"2003","unstructured":"Oie S, Uematsu T, Sawa A, Mizuno H, Tomita M, Ishida S, et al. In vitro effects of combinations of antipseudomonal agents against seven strains of multidrug-resistant Pseudomonas aeruginosa. J Antimicrob Chemother 2003; 52: 911\u2013914.","journal-title":"J Antimicrob Chemother"},{"key":"8342_CR18","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/j.1469-0691.2008.02061.x","volume":"14","author":"N. Petrosillo","year":"2008","unstructured":"Petrosillo N, Ioannidou E, Falagas ME: Colistin monotherapy vs. combination therapy: evidence from microbiological, animal and clinical studies. Clin Microbiol Infect 2008; 14: 816\u2013827.","journal-title":"Clin Microbiol Infect"},{"key":"8342_CR19","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1136\/thx.52.11.987","volume":"52","author":"S.P. Conway","year":"1997","unstructured":"Conway SP, Pond MN, Watson A, Etherington C, Robey HL, Goldman MH: Intravenous colistin sulphomethate in acute respiratory exacerbations in adult patients with cystic fibrosis. Thorax 1997; 52: 987\u2013993.","journal-title":"Thorax"},{"key":"8342_CR20","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1183\/09031936.98.12030592","volume":"12","author":"M.J. Ledson","year":"1998","unstructured":"Ledson MJ, Gallagher MJ, Cowperthwaite C, Convery RP, Walshaw MJ: Four years\u2019 experience of intravenous colomycin in adult cystic fibrosis unit. Eur Respir J 1998; 12: 592\u2013594.","journal-title":"Eur Respir J"},{"key":"8342_CR21","doi-asserted-by":"crossref","first-page":"R78","DOI":"10.1186\/cc2358","volume":"7","author":"N. Markou","year":"2003","unstructured":"Markou N, Apostolakos H, Koumoudiou C, Athanasiou M, Koutsouku A, Alamanos I, Gregorakus L: Intravenous colistin in the treatment of sepsis from multi-resistant Gram-negative bacilli in critically ill patients. Crit Care 2003; 7: R78\u2013R83.","journal-title":"Crit Care"},{"key":"8342_CR22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2334-5-1","volume":"5","author":"M.E. Falagas","year":"2005","unstructured":"Falagas ME, Rizos M, Bliziotis IA, Rellos K, Kasiakou K, Michalopoulos AS: Toxicity after prolonged (more than four weeks) administration of intravenous colistin. BMC Infect Dis 2005; 5: 1.","journal-title":"BMC Infect Dis"},{"key":"8342_CR23","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1128\/AAC.47.8.2659-2662.2003","volume":"47","author":"J.P. Ouderkirk","year":"2003","unstructured":"Ouderkirk JP, Nord JA, Turett GS, Kislak JW: Polimixin B nefrotoxicity and efficacy against nosocomial infections caused by multiresistant gram-negative bacteria. Antimicrob Agents Chemother 2003; 47: 2659\u20132662.","journal-title":"Antimicrob Agents Chemother"},{"key":"8342_CR24","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1086\/502082","volume":"23","author":"G. Bukholm","year":"2002","unstructured":"Bukholm G, Tannaes T, Kjelsberg AB, Smith-Erichsen N: An outbreak of multidrug-resistant Pseudomonas aeruginosa associated with increased risk of patient death in an intensive care unit. Infect Control Hosp Epidemiol 2002; 23: 441\u2013446.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"8342_CR25","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1128\/CMR.00006-08","volume":"21","author":"D. Landman","year":"2008","unstructured":"Landman D, Georgescu C, Martin A, Quale J: Polymyxins revisited. Clin Microbiol Rev 2008; 21: 449\u2013465.","journal-title":"Clin Microbiol Rev"}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-009-8342-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s15010-009-8342-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-009-8342-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T08:27:57Z","timestamp":1589876877000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s15010-009-8342-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6,4]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["8342"],"URL":"https:\/\/doi.org\/10.1007\/s15010-009-8342-x","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,6,4]]}}}